Overestimating product reserves as loss of exclusivity (LoE) approaches can be a $75-million mistake
Joshua I. Halpern
Advertisement
Articles by Joshua I. Halpern
Advertisement
Latest Updated Articles
- Forecasting Returns When Patents Expire
Published: April 8th 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Confirms Cost Plus Drugs Partnership
2
Why Rising Complexity and R&D Costs Are Fueling Specialty Drug Spending
3
Pharma Pulse: Telehealth Medication Abortion Requests Surge, FDA Expedites Tzield Review, and New Biopharma Air Network Launches
4
Pharma Pulse: Amazon Enters Weight-Loss Drug Market, Merck Expands US Manufacturing, and FDA Approves Tezspire for Chronic Sinusitis
5
